Primary Objectives: Demonstrate sensitivity and specificity of neurodiagnostic algorithms exceed FDA targets.
Relevant previously accepted minimum performance targets by the FDA for devices in the area of large vessel occlusion stroke and intracerebral haemorrhage:80% sensitivity and specificity.
EMV Price at posting:
$1.79 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)